GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » EBITDA Margin %

Lexagene Holdings (Lexagene Holdings) EBITDA Margin % : -3,565.12% (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lexagene Holdings's EBITDA for the three months ended in Nov. 2022 was $-1.53 Mil. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was $0.04 Mil. Therefore, Lexagene Holdings's EBITDA margin for the quarter that ended in Nov. 2022 was -3,565.12%.


Lexagene Holdings EBITDA Margin % Historical Data

The historical data trend for Lexagene Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings EBITDA Margin % Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -16,024.14 -13,380.00

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,312.50 15,350.00 -13,080.00 -3,183.61 -3,565.12

Competitive Comparison of Lexagene Holdings's EBITDA Margin %

For the Medical Devices subindustry, Lexagene Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's EBITDA Margin % falls into.



Lexagene Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lexagene Holdings's EBITDA Margin % for the fiscal year that ended in Feb. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Feb. 2022 )/Revenue (A: Feb. 2022 )
=-10.035/0.075
=-13,380.00 %

Lexagene Holdings's EBITDA Margin % for the quarter that ended in Nov. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Nov. 2022 )/Revenue (Q: Nov. 2022 )
=-1.533/0.043
=-3,565.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lexagene Holdings  (OTCPK:LXXGQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Lexagene Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.